fda warning on compounded semaglutide Bullish for #tirzepatide and #semaglutide ?? Comment “article” for the full story! Bullish for compounded #tirzepatide and
Description
Hims & Hers is launching a tracker of GLP-1 shortages to push back against the FDA's recent moves to end compounding copycats of the blockbuster drugs.
Grns fills the nutrition gaps you and 90% of people have
Fast, 7-day delivery if prescribed, plus expert support every step of the way
Use 23 times per week for best results
Tuesday, May 5th 7:30 PM EST | 4:30 PM PST Cant attend live
Read more: #GLP1 #Telehealth #FDA #HealthcareCompliance #CompoundingPharmacy #DigitalHealth #FrierLevitt
